Skip to main content
Dr. Parag H. Mehta
Search
Board Review · Medicine Simplified

Oncology

7 high-yield topics. Open a topic to review its pearls.

Breast Cancer

Risk, screening, staging

Risk Factors

  • Age, BRCA1/2, prior breast cancer, family history
  • Menarche <12, menopause >55, nulliparity
  • Hormone therapy, alcohol, obesity

Screening

  • Mammography age 40-50 (individualized)
  • Clinical breast exam + mammogram annually
  • Self breast exam no longer a screening test
  • BRCA testing with strong family history of breast AND ovarian cancer
  • Implants: mammogram with multiple views

Staging

  • TNM classification
  • ER/PR status, HER2 status

Lymphoma

Hodgkin and non-Hodgkin

Hodgkin

  • Reed-Sternberg cells
  • Nodular sclerosis most common
  • B symptoms: fever, night sweats, weight loss
  • Treatment: ABVD chemotherapy

Non-Hodgkin

  • Indolent: follicular, marginal zone
  • Aggressive: DLBCL, Burkitt
  • DLBCL: R-CHOP regimen

Paraneoplastic Syndromes

Metabolic and neurologic

Metabolic

  • SIADH: small cell lung cancer → hyponatremia
  • Hypercalcemia: PTHrP (squamous cell lung, renal, breast)
  • Hypoglycemia: large cell lymphomas

Neurologic

  • Lambert-Eaton: anti-VGCC (small cell lung)
  • Cerebellar degeneration: anti-Yo, anti-Tr
  • Limbic encephalitis: anti-Hu

Prostate Cancer

Screening and treatment

Key Points

  • PSA age ≥50 annually, discuss limitations
  • Not shown to reduce mortality — shared decision making
  • DRE and PSA; if abnormal, ultrasound and biopsy
  • Treatment depends on stage, grade (Gleason), and life expectancy

GI & GU Malignancies

Testicular, bladder, colon

Testicular

  • Young men, painless mass
  • Markers: AFP, beta-hCG, LDH
  • Highly treatable even when metastatic

Bladder

  • Painless hematuria, smoking, aniline dyes
  • Cystoscopy for diagnosis

Colon

  • See GI section for screening
  • CEA for monitoring, not screening

Melanoma

ABCDE and staging

Key Points

  • ABCDE: Asymmetry, Border, Color, Diameter >6mm, Evolving
  • Breslow depth is key prognostic factor
  • Excisional biopsy for diagnosis
  • Sun avoidance best prevention

Anti-tumor Drug Side Effects

Key toxicities

Common Toxicities

  • Doxorubicin/anthracyclines: cardiotoxicity
  • Bleomycin: pulmonary fibrosis
  • Cisplatin: nephrotoxicity, ototoxicity, neuropathy
  • Vincristine: peripheral neuropathy
  • Cyclophosphamide: hemorrhagic cystitis (give mesna)
  • Methotrexate: mucositis, myelosuppression (give leucovorin)